199 related articles for article (PubMed ID: 29707741)
1. Myocardial Energetics and Heart Failure: a Review of Recent Therapeutic Trials.
Bhatt KN; Butler J
Curr Heart Fail Rep; 2018 Jun; 15(3):191-197. PubMed ID: 29707741
[TBL] [Abstract][Full Text] [Related]
2. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
Sabbah HN; Gupta RC; Kohli S; Wang M; Hachem S; Zhang K
Circ Heart Fail; 2016 Feb; 9(2):e002206. PubMed ID: 26839394
[TBL] [Abstract][Full Text] [Related]
3. [Levosimendan in heart failure].
Scelsi L; Campana C; Ghio S; Monti L; Opasich C; De Feo S; Cobelli F; Orlandi M; Di Pasquale G; Tavazzi L
Recenti Prog Med; 2004; 95(7-8):376-83. PubMed ID: 15303549
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
Dieterich HA; Wendt C; Saborowski F
Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
[TBL] [Abstract][Full Text] [Related]
5. Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials.
Ahmad T; Miller PE; McCullough M; Desai NR; Riello R; Psotka M; Böhm M; Allen LA; Teerlink JR; Rosano GMC; Lindenfeld J
Eur J Heart Fail; 2019 Sep; 21(9):1064-1078. PubMed ID: 31407860
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options.
Hamilton DJ
Methodist Debakey Cardiovasc J; 2017; 13(1):25-28. PubMed ID: 28413579
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for acute and chronic heart failure: current and future developments.
Chen SY; Tang WH
Expert Opin Emerg Drugs; 2007 Mar; 12(1):75-95. PubMed ID: 17355215
[TBL] [Abstract][Full Text] [Related]
8. Chronic heart failure: what does the horizon look like?
Estep JD
Curr Opin Cardiol; 2015 Jul; 30(4):344-53. PubMed ID: 26049379
[TBL] [Abstract][Full Text] [Related]
9. Ivabradine: Current and Future Treatment of Heart Failure.
Thorup L; Simonsen U; Grimm D; Hedegaard ER
Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):89-97. PubMed ID: 28371247
[TBL] [Abstract][Full Text] [Related]
10. Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure.
Holubarsch C; Hasenfuss G; Thierfelder L; Just H
Basic Res Cardiol; 1991; 86 Suppl 1():107-12. PubMed ID: 1827977
[TBL] [Abstract][Full Text] [Related]
11. The utility of levosimendan in the treatment of heart failure.
Lehtonen L; Põder P
Ann Med; 2007; 39(1):2-17. PubMed ID: 17364447
[TBL] [Abstract][Full Text] [Related]
12. Direct Myosin Activation by Omecamtiv Mecarbil for Heart Failure with Reduced Ejection Fraction.
Psotka MA; Teerlink JR
Handb Exp Pharmacol; 2017; 243():465-490. PubMed ID: 28315072
[TBL] [Abstract][Full Text] [Related]
13. [Rationale and clinical evidence for the effects of new pharmacological treatments for heart failure].
Tamargo J; López-Sendón J
Rev Esp Cardiol; 2004 May; 57(5):447-64. PubMed ID: 15151778
[TBL] [Abstract][Full Text] [Related]
14. Future pharmacologic agents for treatment of heart failure in children.
Moffett BS; Chang AC
Pediatr Cardiol; 2006; 27(5):533-51. PubMed ID: 16933064
[TBL] [Abstract][Full Text] [Related]
15. The high-risk patient with heart failure with reduced ejection fraction: treatment options and challenges.
Bartos JA; Francis GS
Clin Pharmacol Ther; 2013 Oct; 94(4):509-18. PubMed ID: 23852394
[TBL] [Abstract][Full Text] [Related]
16. Vasodilator therapy for decompensated heart failure.
Yancy CW
J Am Coll Cardiol; 2008 Jul; 52(3):208-10. PubMed ID: 18617069
[No Abstract] [Full Text] [Related]
17. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
Scolletta S; Biagioli B
Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
[TBL] [Abstract][Full Text] [Related]
18. Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker.
Konstantinou DM; Karvounis H; Giannakoulas G
Cardiology; 2016; 134(3):311-9. PubMed ID: 26959501
[TBL] [Abstract][Full Text] [Related]
19. Novel therapies in acute and chronic heart failure.
Aronson D; Krum H
Pharmacol Ther; 2012 Jul; 135(1):1-17. PubMed ID: 22475446
[TBL] [Abstract][Full Text] [Related]
20. Update of recent clinical trials in heart failure and myocardial infarction.
Richardson M; Cockburn N; Cleland JG
Eur J Heart Fail; 1999 Mar; 1(1):109-15. PubMed ID: 10937988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
